Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men worldwide. Immunotherapy is an emerging treatment modality for cancers that harnesses the immune system’s ability to eliminate tumor cells. In particular, dendritic cell (DC) vaccines, have demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhshi, Parisa, Nourizadeh, Maryam, Sharifi, Laleh, Farajollahi, Mohammad M., Mohsenzadegan, Monireh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638778/
https://www.ncbi.nlm.nih.gov/pubmed/37951911
http://dx.doi.org/10.1186/s12935-023-03108-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638778/
https://www.ncbi.nlm.nih.gov/pubmed/37951911
http://dx.doi.org/10.1186/s12935-023-03108-0

Ejemplares similares